Literature DB >> 24392386

"Neonatal Sepsis": Bacteria & their Susceptibility Pattern towards Antibiotics in Neonatal Intensive Care Unit.

Chandra Madhur Sharma1, Ravi Prakash Agrawal1, Hariom Sharan2, Bijay Kumar3, Deepti Sharma4, Santokh Singh Bhatia5.   

Abstract

BACKGROUND: Neonatal sepsis is one of the most common causes of neonatal mortality and morbidity, particularly in the developing countries. Its causative bacteria and their respective sensitivity patterns are different in each hospital and region. The objective of this study was to determine the causative bacteria and pattern of susceptibility to antibiotics in NICU of a tertiary care centre, which in turn may help in implementation of empirical therapy.
MATERIAL AND METHODS: This prospective study was carried out at a medical college during the period from 1st April 2011 to 31st March 2013. A total of 364 cases of suspected sepsis were admitted in our NICU during the mentioned period. Out of which, 137 cases were positive for culture. All the neonates of suspected sepsis were screened by using a panel consisting of CRP, ANC, I/T ratio, micro ESR and culture and sensitivity.
RESULTS: A total of 137 cultures were found to be positive out of 364 cases. The most common organism isolated was Staphylococcus aureus (37.22%) followed by Klebsiella pneumoniae (27.01%) and Escherichia coli (19.70%). Other organisms were much less in number, which included pathogenic Streptococci, Coagulase negative Staphylococci (CoNS), Pseudomonas, Acinetobacter and Enterobacter species. The gram positive organisms except Streptococci displayed a high degree of resistance to most penicillins and ciprofloxacin but were sensitive to vancomycin, amikacin and cefepime. There was a high incidence of resistance noted with ampicillin, gentamicin and ciprofloxacin amongst most gram negative organisms' where-in cefepime, amikacin and meropenem were effective in most cases.
CONCLUSION: There is an increasing trend of antibiotic resistance to the commonly used first line drugs. Continuous surveillance for antibiotic susceptibility is needed to ensure proper empirical therapy.

Entities:  

Keywords:  Antimicrobial sensitivity; Early onset sepsis; Empirical therapy; Late onset sepsis; Neonates

Year:  2013        PMID: 24392386      PMCID: PMC3879858          DOI: 10.7860/JCDR/2013/6796.3594

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

Review 1.  Blood cultures in newborns and children: optimising an everyday test.

Authors:  J P Buttery
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-07       Impact factor: 5.747

2.  Aetiology and antimicrobial resistance of neonatal sepsis at a tertiary care centre in eastern India: a 3 year study.

Authors:  Rajlakshmi Viswanathan; Arun Kumarendu Singh; Suchandra Mukherjee; Ranajit Mukherjee; Parijat Das; Sulagna Basu
Journal:  Indian J Pediatr       Date:  2010-10-17       Impact factor: 1.967

3.  Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.

Authors:  Mohamed S Ellabib; Adoracion Ordonez; Asma Ramali; Amala Walli; Touria Benayad; Hafida Shebrlo
Journal:  Saudi Med J       Date:  2004-12       Impact factor: 1.484

4.  Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India.

Authors:  A T Bang; R A Bang; S B Baitule; M H Reddy; M D Deshmukh
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

5.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group.

Authors: 
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

6.  Risk factors for early onset neonatal group B streptococcal sepsis: case-control study.

Authors:  Sam Oddie; Nicholas D Embleton
Journal:  BMJ       Date:  2002-08-10

7.  Neonatal sepsis bacterial isolates and antibiotic susceptibility patterns at a NICU in a tertiary care hospital in western Nepal: a retrospective analysis.

Authors:  C K Shaw; P Shaw; A Thapalial
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2007 Apr-Jun

Review 8.  The global impact of neonatal infection.

Authors:  B J Stoll
Journal:  Clin Perinatol       Date:  1997-03       Impact factor: 3.430

9.  Increased prevalence of extended spectrum beta lactamase producers in neonatal septicaemic cases at a tertiary referral hospital.

Authors:  A Bhattacharjee; M R Sen; P Prakash; A Gaur; S Anupurba
Journal:  Indian J Med Microbiol       Date:  2008 Oct-Dec       Impact factor: 0.985

10.  Antibiotic sensitivity pattern of causative organisms of neonatal septicemia in an urban hospital of Bangladesh.

Authors:  Forhad Monjur; Farhana Rizwan; Muhammad Asaduzzaman; Nishat Nasrin; Nobo Krishna Ghosh; Apurba Sarker Apu; Fazlul Haque
Journal:  Indian J Med Sci       Date:  2010-06
View more
  13 in total

1.  Diversity of clonal types of Klebsiella pneumoniae causing infections in intensive care neonatal patients in a large urban setting.

Authors:  Livia Helena Justo-da-Silva; Andrea Nunes De-Azeredo; Arnaldo Costa Bueno; Lara Feital Montezzi; Maria Beatriz Gerardin Poirot Leobons; Maria Silvana Alves; Patrícia de Souza Inhaquite; Rosana Rangel Santos; Valéria Brígido Carvalho Girão; Antônio José Ledo Alves da Cunha; Carmem Lucia Pessoa-Silva; Renata Cristina Picão; Cristina Barroso Hofer; Guilherme Santoro-Lopes; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

2.  Bacteraemia and antibiotic sensitivity in a tertiary neonatal intensive care unit.

Authors:  Hamida van Staaden; Candice Hendricks; Kevin Spicer
Journal:  S Afr J Infect Dis       Date:  2021-01-05

3.  Syndrome Evaluation System (SES) versus Blood Culture (BACTEC) in the Diagnosis and Management of Neonatal Sepsis--A Randomized Controlled Trial.

Authors:  B Vishnu Bhat; P Prasad; Venkata Banda Ravi Kumar; B N Harish; K Krishnakumari; Anand Rekha; G Manjunath; B Adhisivam; B Shruthi
Journal:  Indian J Pediatr       Date:  2016-01-06       Impact factor: 1.967

4.  Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.

Authors:  Stephen P Bergin; Joshua T Thaden; Jessica E Ericson; Heather Cross; Julia Messina; Reese H Clark; Vance G Fowler; Daniel K Benjamin; Christoph P Hornik; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2015-09       Impact factor: 3.806

5.  Neonatal sepsis in a tertiary unit in South Africa.

Authors:  Dharshni Pillay; Lerusha Naidoo; Khine Swe Swe-Han; Yesholata Mahabeer
Journal:  BMC Infect Dis       Date:  2021-02-27       Impact factor: 3.090

6.  A Systemic Review and Meta-analysis of the Leading Pathogens Causing Neonatal Sepsis in Developing Countries.

Authors:  Desalegne Amare Zelellw; Getenet Dessie; Endalkachew Worku Mengesha; Melashu Balew Shiferaw; Masresha Mela Merhaba; Solomon Emishaw
Journal:  Biomed Res Int       Date:  2021-06-05       Impact factor: 3.411

7.  Sepsis in cancer patients residing in Zimbabwe: spectrum of bacterial and fungal aetiologies and their antimicrobial susceptibility patterns.

Authors:  Frank Chinowaita; Wendy Chaka; Tinashe K Nyazika; Tendai C Maboreke; Emmanuel Tizauone; Prichard Mapondera; Inam Chitsike; Andrew Z Cakana; Rooyen T Mavenyengwa
Journal:  BMC Infect Dis       Date:  2020-02-21       Impact factor: 3.090

Review 8.  Neonatal Sepsis.

Authors:  Muhammed Ershad; Ahmed Mostafa; Maricel Dela Cruz; David Vearrier
Journal:  Curr Emerg Hosp Med Rep       Date:  2019-06-19

9.  Pattern of bacterial profile and antibiotic susceptibility among neonatal sepsis cases at Cairo University Children Hospital.

Authors:  Mohammad N Almohammady; Eman M Eltahlawy; Nashwa M Reda
Journal:  J Taibah Univ Med Sci       Date:  2020-02-04

10.  Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.

Authors:  Sophie C H Wen; Yukiko Ezure; Lauren Rolley; Geoff Spurling; Colleen L Lau; Saba Riaz; David L Paterson; Adam D Irwin
Journal:  PLoS Med       Date:  2021-09-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.